Hepatitis C virus (HCV) is the most common blood-borne infection in the United States. HCV infection is a leading cause of chronic liver disease, end-stage liver disease, and liver transplantation. Newly available therapies can clear HCV in most infected persons who receive treatment. However, many persons living with HCV infection are unaware of their infection status, including those born during 1945-1965 (a population at increased risk for chronic hepatitis C in the United States). This review highlights the epidemiology of hepatitis C and the importance of HCV testing and linkage to care in an era of more effective antiviral therapies.
Published by Elsevier Inc.